VIAP OTC
VIA Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -94.4%
5Y: -93.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$6M
+54.6% ▲
Net Income
-$10M
+54.2% ▲
EPS (Diluted)
$-0.47
+55.2% ▲
EBITDA
-$6M
+55.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2006 | FY2007 | FY2008 | FY2009 | FY2010 |
|---|---|---|---|---|---|
| Revenue | $83K | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | -100.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $62K | $119K | $206K | $136K | $75K |
| Gross Profit | $22K | $0 | $0 | $0 | $0 |
| Gross Margin | 25.9% | — | — | — | — |
| R&D Expenses | $6M | $11M | $12M | $6M | $2M |
| SG&A Expenses | $3M | $8M | $9M | $7M | $4M |
| Operating Expenses | $8M | $22M | $20M | $13M | $6M |
| Operating Income | -$8M | -$22M | -$20M | -$13M | -$6M |
| Operating Margin | -9868.1% | — | — | — | — |
| Interest Expense | $498K | $60K | $6K | $8M | $4M |
| Income Before Tax | $0 | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$9M | -$22M | -$20M | -$21M | -$10M |
| Net Margin | -10352.3% | — | — | — | — |
| EPS (Diluted) | $-1.74 | $-2.24 | $-1.03 | $-1.05 | $-0.47 |
| EBITDA | -$8M | -$18M | -$20M | -$13M | -$6M |
| Shares Outstanding | 5M | 10M | 20M | 20M | 20M |